Hemlibra

Digital Pharmacist

The RxWiki Digital Pharmacist stamp of approval lets you know that this content has been created and reviewed by a licensed pharmacist.

Hemlibra prevents bleeding episodes in adults and children with hemophilia A. Hemlibra is injected once weekly.

Hemlibra Overview

Reviewed: November 21, 2017
Updated: 

Hemlibra is a prescription medication used to prevent bleeding episodes in adults and children with hemophilia A (factor VIII deficiency) with factor VIII inhibitors, or factor VIII antibodies.

Hemlibra belongs to a group of drugs called blood coagulation factors. These work to activate substances in your blood to form clots and decrease bleeding episodes.

This medication is available in an injectable form to be given directly under the skin (subcutaneously) once weekly.

Common side effects of Hemlibra include a reaction at the site of injection, headache, and joint pain.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Hemlibra Drug Class

Back to Top

Hemlibra is part of the drug class:

Hemlibra FDA Warning

Back to Top

WARNING: THROMBOTIC MICROANGIOPATHY AND THROMBOEMBOLISM

Cases of thrombotic microangiopathy and thrombotic events were reported when on average a cumulative amount of >100 U/kg/24 hours of activated prothrombin complex concentrate was administered for 24 hours or more to patients receiving HEMLIBRA prophylaxis. Monitor for the development of thrombotic microangiopathy and thrombotic events if aPCC is administered. Discontinue aPCC and suspend dosing of HEMLIBRA if symptoms occur.